Organigram (NASDAQ:OGI) Issues Earnings Results, Misses Expectations By $0.02 EPS

Organigram (NASDAQ:OGI) released its quarterly earnings data on Tuesday. The company reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.02), Zacks reports. Organigram had a negative return on equity of 11.68% and a negative net margin of 28.58%.

Organigram Stock Down 16.8 %

Shares of NASDAQ OGI opened at $1.44 on Wednesday. Organigram has a 12-month low of $1.31 and a 12-month high of $2.91. The firm’s 50-day moving average is $1.57 and its two-hundred day moving average is $1.67.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.